Effects of neural stem cells on synaptic proteins and memory in a mouse model of Alzheimer's disease

Journal of Neuroscience Research

Volumn 92, Issue 2, 2014, Pages 185-194

  Zhang, W ^a   Wang, G M ^b   Wang, P J ^a   Zhang, Q ^c   Sha, S H ^b  

^a TONGJI UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Alzheimer's disease; GAP 43; Neural stem cells; Synaptophysin

Indexed keywords

AMYLOID PRECURSOR PROTEIN; NEUROMODULIN; PRESENILIN 1; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOFLUORESCENCE; MEMORY; MITOCHONDRION SWELLING; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; POSTSYNAPTIC DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPATIAL LEARNING; SYNAPSE VESICLE; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ALZHEIMER'S DISEASE; GAP-43; NEURAL STEM CELLS; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; GAP-43 PROTEIN; MEMORY; MICE; MICE, TRANSGENIC; NEURAL STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; SYNAPTOPHYSIN;

EID: 84890128743     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23299     Document Type: Article

References (45)

1. Arendt T. 2009. Synaptic degeneration in Alzheimer's disease. Acta Neuropathol 118:167-179.
2. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. 2005. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45:675-688.
3. Birmingham K, Frantz S. 2002. Set back to Alzheimer vaccine studies. Nat Med 8:199-200.
4. Blennow K, de Leon MJ, Zetterberg H. 2006. Alzheimer's disease. Lancet 368:387-403.
5. Blennow K, Zetterberg H, Rinne JO, Salloway S, Wei J, Black R, Grundman M, Liu E. 2012. Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease. Arch Neurol 69:1002-1010.
6. Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Müller FJ, Loring JF, Yamasaki TR, Poon WW, Green KN, LaFerla FM. 2009. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A 106:13594-13599.
7. Calhoun ME, Jucker M, Martin LJ, Thinakaran G, Price DL, Mouton PR. 1996. Comparative evaluation of synaptophysin-based methods for quantification of synapses. J Neurocytol 25:821-828.
8. Carlson C, Estergard W, Oh J, Suhy J, Jack CR Jr, Siemers E, Barakos J. 2011. Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab. Alzheimers Dement 7:396-401.
9. Chen SQ, Cai Q, Shen YY, Wang PJ, Teng GJ, Li MH, Zhang W, Zang FC. 2012. 1H-MRS evaluation of therapeutic effect of neural stem cell transplantation on Alzheimer's disease in AβPP/PS1 double transgenic mice. J Alzheimers Dis 28:71-80.
10. Demars M, Hu YS, Gadadhar A, Lazarov O. 2010. Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice. J Neurosci Res 88:2103-2117.
11. Ebert AD, Beres AJ, Barber AE, Svendsen CN. 2008. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. Exp Neurol 209:213-223.
12. Forman MS, Trojanowski JQ, Lee VM. 2004. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10:1055-1063.
13. Hamos JE, DeGennaro LJ, Drachman DA. 1989. Synaptic loss in Alzheimer's disease and other dementias. Neurology 39:355-361.PMID: 2927643.
14. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, Mucke L. 1999. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A 96:3228-3233.
15. Imbimbo BP, Giardina GA. 2011. γ-Secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes. Curr Top Med Chem 1:1555-1570.
16. Janz R, Südhof TC, Hammer RE, Unni V, Siegelbaum SA, Bolshakov VY. 1999. Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I. Neuron 24:687-700.
17. Kiyota T, Yamamoto M, Schroder B, Jacobsen MT, Swan RJ, Lambert MP, Klein WL, Gendelman HE, Ransohoff RM, Ikezu T. 2009. AAV1/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, beta-amyloidosis, and learning impairment of APP/PS1 mice. Mol Ther 17:803-809.
18. Kiyota T, Ingraham KL, Swan RJ, Jacobsen MT, Andrews SJ, Ikezu T. 2011. AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice. Gene Ther 19:724-733.
19. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL. 2007. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27:796-807.
20. Lu P, Jones LL, Snyder EY, Tuszynski MH. 2003. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 181:115-129.
21. Marjanska M, Curran GL, Wengenack TM, Henry PG, Bliss RL, Poduslo JF, Jack CR Jr, Ugurbil K, Garwood M. 2005. Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 102:11906-11910.
22. Mattson MP. 2004. Pathways towards and away from Alzheimer's disease. Nature 430:631-639.
23. Maviel T, Durkin TP, Menzaghi F, Bontempi B. 2004. Sites of neocortical reorganization critical forremote spatial memory. Science 305:96-99.
24. Moechars D, Dewachter I, Lorent K, Reversé D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Haute CV, Checler F, Godaux E, Cordell B, Van Leuven F. 1999. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. Biol Chem 274:6483-6492.
25. Morris R. 1984. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47-60.
26. Musia A, Bajda M, Malawska B. 2007. Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment. Curr Med Chem 14:2654-2679.
27. Nagahara AH, Bernot T, Moseanko R, Brignolo L, Blesch A, Conner JM, Ramirez A, Gasmi M, Tuszynski MH. 2009. Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery. Exp Neurol 215:153-159.
28. Nomura T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. 2005. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 136:161-169.
29. Park D, Lee HJ, Joo SS, Bae DK, Yang G, Yang YH, Lim I, Matsuo A, Tooyama I, Kim YB, Kim SU. 2012. Human neural stem cells over-expressing choline acetyltransferase restore cognition in rat model of cognitive dysfunction. Exp Neurol 234:521-526.
30. Perry EK, Johnson M, Ekonomou A, Perry RH, Ballard C, Attems J. 2012. Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiol Dis 47:155-162.
31. Postina R, Schroeder A, Dewachter I, Bohl J, Schmitt U, Kojro E, Prinzen C, Endres K, Hiemke C, Blessing M, Flamez P, Dequenne A, Godaux E, van Leuven F, Fahrenholz F. 2004. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 113:1456-1464.
32. Ripoli C, Piacentini R, Riccardi E, Leone L, Li Puma DD, Bitan G, Grassi C. 2013. Effects of different amyloid β-protein analogues on synaptic function. Neurobiol Aging 34:1032-1044.
33. Routtenberg A, Cantallops I, Zaffuto S, Serrano P, Namgung U. 2000. Enhanced learning after genetic overexpression of a brain growth protein. Proc Natl Acad Sci U S A 97:7657-7662.
34. Russell CL, Semerdjieva S, Empson RM, Austen BM, Beesley PW, Alifragis P. 2012. Amyloid-β acts as a regulator of neurotransmitter release disrupting the interaction between synaptophysin and VAMP2. PLoS One 7:e43201.
35. Selkoe DJ. 2002. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease. J Clin Invest 110:1375-1381.
36. Selkoe DJ. 2012. Alzheimer's disease is a synaptic failure. Science 298:789-791.
37. Sher F, Boddeke E, Olah M, Copray S. 2012. Dynamic changes in Ezh2 gene occupancy underlie its involvement in neural stem cell self-renewal and differentiation towards oligodendrocytes. PLoS One 7:e40399.
38. Sivanesan S, Tan A, Rajadas J. 2013. Pathogenesis of abeta oligomers in synaptic failure. Curr Alzheimer Res 10:316-323.
39. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R. 1991. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580.
40. Tuszynski MH. 2009. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 15:331-337.
41. Verzé L, Paraninfo A, Ramieri G, Viglietti-Panzica C, Panzica GC. 1999. Immunocytochemical evidence of plasticity in the nervous structures of the rat lower lip. Cell Tissue Res 297:203-211.
42. Xuan AG, Luo M, Ji WD, Long DH. 2009. Effects of engrafted neural stem cells in Alzheimer's disease rats. Neurosci Lett 450:167-171.
43. Yamasaki TR, Blurton-Jones M, Morrissette DA, Kitazawa M, Oddo S, LaFerla FM. 2007. Neural stem cells improve memory in an inducible mouse model of neuronal loss. J Neurosci 27:11925-11933.
44. Young E, Cesena T, Meiri KF, Perrone-Bizzozero NI. 2002. Changes in protein kinase C (PKC) activity, isozyme translocation, and GAP-43 phosphorylation in the rat hippocampal formation after a single-trial contextual fear conditioning paradigm. Hippocampus 12:457-464.
45. Zhang Q, Wu Y, Zhang P, Sha H, Jia J, Hu Y, Zhu J. 2012. Exercise induces mitochondrial biogenesis after brain ischemia in rats. Neuroscience 205:10-17.